|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Exploration and evaluation assets | |||||||||
| Property, plant and equipment | |||||||||
| Right of use assets | |||||||||
| Derivative financial assets | |||||||||
| Deferred tax asset | |||||||||
| Total non-current assets | |||||||||
| Income tax receivable | |||||||||
| Inventories | |||||||||
| Trade and other receivables | |||||||||
| Prepayments | |||||||||
| Fixed term deposit | |||||||||
| Cash and cash equivalents | |||||||||
| Assets held for sale | |||||||||
| Total current assets | |||||||||
| Total assets | |||||||||
| Equity and liabilities | |||||||||
| Share capital | |||||||||
| Reserves | |||||||||
| Retained loss | |||||||||
| Equity attributable to shareholders of the parent | |||||||||
| Non-controlling interests | |||||||||
| Total equity | |||||||||
| Liabilities | |||||||||
| Deferred tax liabilities | |||||||||
| Provisions | |||||||||
| Loans and borrowings | |||||||||
| Loan note instruments | |||||||||
| Cash-settled share-based payment | |||||||||
| Lease liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Income tax payable | |||||||||
| Loan notes - short term portion | |||||||||
| Derivative financial liabilities | |||||||||
| Trade and other payables | |||||||||
| Overdrafts | |||||||||
| Liabilities associated with assets held for sale | |||||||||
| Total current liabilities | |||||||||
| Total liabilities | |||||||||
| Total equity and liabilities | |||||||||
Loading...
